2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
LG¿¡³ÊÁö¼Ö·ç¼Ç, ¹Ì±¹ ž籤 Àü±âÂ÷¿¡µµ ¹èÅ͸® °ø±ÞÇÑ´Ù (2025-01-29)
À¯±â ¹ß±¤´ÙÀÌ¿ÀµåÀÇ °áÁ¤Àû ¼º´É °¨¼Ò ¸ÞÄ¿´ÏÁò ±Ô¸í (2024-10-29)
Bureau Veritas Strengthens Its Positioning in Luxury and Fas... (2024-12-10)
¡®ÀüÇö¹«°èȹ2¡¯ ÀüÇö¹«X°ûÆ©ºê, À̹ø¿£ ¼øÃµÀÌ´Ù (2024-11-15)
º¯À̾ϺÎÅÍ Ç×¾ÏÁ¦ ³»¼º±îÁö ±Øº¹¡¦ ³­Ä¡¾Ï Ä¡·á »õ ½Ã´ë ¿¬´Ù (2024-12-27)
IRIS2 lifts off as European Commission and SpaceRISE sign co... (2024-12-27)
AI ±â¹Ý ÀÇ·á °æ¿µ ÃÖÀûÈ­ ¼Ö·ç¼Ç ¡®¸Þµð¹ö´Ï¡¯ °³¹ß º»°ÝÈ­ (2024-10-05)
¡®¼± ³ÑÀº ÆÐ¹Ð¸®¡¯ ¾ÈÁ¤È¯ ¡°ÀÌÇý¿ø, º¸¾ç½Ä ÇØÁØ Àû ¾ø´Âµ¥¡¦... (2024-08-16)
½ºÀ§½º ÆÐ¹Ð¸®, »õÇØ¿¡µµ ¸ø ¸»¸®´Â ¡®¿µÅ¹ »ç¶û¡¯ Åõ¾î 2ź (2025-01-30)
SBC Medical Group Co., Ltd. Sells Two Subsidiaries (2025-01-05)
Burger King¢ç Japan Announces the Japan-exclusive Release of... (2024-11-16)
»óȣȣȯ¼º ½ÃÇè ¡®K-Plugtest¡¯ ÅëÇØ C-ITS ÃßÁø Ȱ·Â (2024-11-16)
¸¸Æ®·°¹ö½º ±×·ì, ¡®IAA »ó¿ëÂ÷ ¸ðÅͼî 2024¡® Âü°¡ (2024-09-19)
Áö½Ä ³ª´® ¹®È­°­¿¬ ÅëÇÑ ¼öÀÍ±Ý ÀÚ¸³Áغñû³â ÈÄ¿ø (2024-11-08)
Á¦ÁÖ»ï´Ù¼ö, Ä«Æä »ï´ÙÄÚÁö ¡®Å©¸®½º¸¶½º ºô¸®Áö¡¯ ¿ÀÇ (2024-12-03)
À¯¼¼¸°, 1¿ù ÇÑ ´Þ°£ ¡®¿Ã¸®ºê¿µ °­³²Å¸¿îÁ¡¡¯ ÆË¾÷½ºÅä¾î ÁøÇà (2025-01-22)
VeriSilicon¡¯s Ultra-Low Energy NPU Provides Over 40 TOPS fo... (2025-06-21)
GS25, À̸¥ ´õÀ§¿¡ ¡®°£Æí º¸¾ç½Ä¡¯ Á¶±â Ãâ½Ã (2024-06-28)
HDÇö´ëÀÏ·ºÆ®¸¯, À¯·´ ÃÖ´ë Àü·Â¼öÃâ±¹ ½º¿þµ§ ½ÃÀå ù ÁøÃâ (2024-09-11)
¿ì¸®ÀºÇà, ±Û·Î¹ú 455Á¶¿ø ǪµåÅ×Å© ½ÃÀå °ø·« ±ÝÀ¶Áö¿ø (2024-10-06)
¹è¿ì ±èÁöÀº, ³ª¹«¿¢Åͽº¿Í Àü¼Ó°è¾à (2024-11-25)
¡®¼Ö·Î¶ó¼­¡¯ ½Ãû·üXÈ­Á¦¼º ´Ù ÀâÀ¸¸ç ½ÃÁð1 ¸¶°¨ (2024-12-20)
E.B.M, À¯Èñ¶ó¿Í 24 WINTER Ä·ÆäÀÎ (2024-10-23)
°æ»ó³²µµ-â¿øÆ¯·Ê½Ã ¡®Á¦1ȸ ±¹Á¦¿ìÁÖÇ×°ø±â¼ú´ëÀü¡¯ °³ÃÖ (2024-10-23)
»ï¼ºÀüÀÚ, KES 2024¼­ ¸ðµÎ¸¦ À§ÇÑ ¡®AI ¶óÀÌÇÁ¡¯ Á¦¾È (2024-10-23)
       [ÀÌÀü][1]....[390][391][392][393][394][395][396][397][398]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..